Items where authors include "Verghese, ET"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 14.

Article

Baxter, DE, Allinson, LM, Al Amri, WS et al. (5 more authors) (2021) MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer. Cancers, 13 (23). 5979. ISSN 2072-6694

Gwili, N, Jones, SJ, Al Amri, W et al. (15 more authors) (2021) Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response. British Journal of Cancer, 125. pp. 983-993. ISSN 0007-0920

Nair, A, Ingram, N orcid.org/0000-0001-5274-8502, Verghese, ET et al. (5 more authors) (2020) CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma. Cellular Oncology, 43 (5). pp. 835-845. ISSN 2211-3428

Al Amri, WS, Baxter, DE, Hanby, AM orcid.org/0000-0001-7966-1570 et al. (4 more authors) (2020) Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants. Breast Cancer Research and Treatment, 183 (3). pp. 607-616. ISSN 0167-6806

Verma, R, Hanby, AM orcid.org/0000-0001-7966-1570, Horgan, K et al. (4 more authors) (2020) Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer. Breast Cancer Research and Treatment, 183 (1). pp. 49-59. ISSN 0167-6806

Al Amri, WS, Allinson, LM, Baxter, DE orcid.org/0000-0001-8830-6802 et al. (7 more authors) (2020) Genomic and expression analyses define MUC17 and PCNX1 as predictors of chemotherapy response in breast cancer. Molecular Cancer Therapeutics, 19 (3). pp. 945-955. ISSN 1535-7163

Baxter, DE orcid.org/0000-0001-8830-6802, Kim, B, Hanby, AM orcid.org/0000-0001-7966-1570 et al. (3 more authors) (2018) Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy. Clinical Breast Cancer, 18 (6). pp. 481-488. ISSN 1526-8209

Nair, A, Ingram, N orcid.org/0000-0001-5274-8502, Verghese, ET et al. (5 more authors) (2018) Neutrophil Gelatinase-associated Lipocalin as a Theragnostic Marker in Perihilar Cholangiocarcinoma. Anticancer Research, 38 (12). pp. 6737-6744. ISSN 0250-7005

Smith, L, Baxter, EW, Chambers, PA et al. (8 more authors) (2015) Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis. PLoS ONE, 10 (10). e0139698. ISSN 1932-6203

Kim, B, Stephen, SL, Hanby, AM et al. (9 more authors) (2015) Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. BMC Cancer, 15. 634. ISSN 1471-2407

Langlands, FE, Dodwell, D, Hanby, AM et al. (6 more authors) (2014) PSMD9 expression predicts radiotherapy response in breast cancer. Molecular Cancer, 13. 73. ISSN 1476-4598

Touqan, N, Diggle, CP, Verghese, ET et al. (7 more authors) (2013) An observational study on the expression levels of MDM2 and MDMX proteins, and associated effects on P53 in a series of human liposarcomas. BMC Clinical Pathology, 13 (1). 32. pp. 1-9. ISSN 1472-6890

Verghese, ET, Drury, R, Green, CA et al. (10 more authors) (2013) MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion. The Journal of Pathology, 231 (3). pp. 388-399. ISSN 0022-3417

Tiernan, JP, Perry, SL, Verghese, ET et al. (4 more authors) (2013) Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. British Journal of Cancer, 108 (3). 662 - 667. ISSN 0007-0920

This list was generated on Mon Mar 25 00:01:20 2024 GMT.